IP Library › Granted Patent US 10,675,465
Granted Patent B2
US 10,675,465 · App. 15/644,727 · Granted Jun 9, 2020

Methods for treatment of disease using galvanic vestibular stimulation

Inventors: Paul Duncan McGeoch (Del Mar, CA); Vilayanur S. Ramachandran (San Diego, CA)
Assignee: The Regents of the University of California
A61N1/36014A61N1/0408A61N1/0456A61N1/36031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,675,465
App. No.
15/644,727
Granted
Jun 9, 2020
Kind
B2
Abstract

Methods are provided for treating diseases by altering body mass composition in a human subject through application of galvanic vestibular stimulation (GVS) using electrodes placed in electrical contact with the subject's scalp at a location corresponding to each of the subject's left and right vestibular systems. The methods may be used to treat obesity-related diseases such as diabetes, hypertension, type 2 diabetes mellitus and osteoporosis. GVS may be applied for a predetermined period of time at regular intervals.

Claims (13)

1. A method for treating at least one disease in a human subject, the method comprising:

connecting the subject with a device which produces an electrical current by disposing electrodes at the subject's scalp at a location corresponding to each of the subject's left and right vestibular systems; and

treating the at least one disease by applying galvanic vestibular stimulation (GVS) from the device to the subject via the electrodes for a predetermined period of time of approximately one hour at regular intervals, wherein the at least one disease is one or more of diabetes, type 2 diabetes mellitus, hypertension obesity, osteoporosis or an obesity-related disease.

2. The method of claim 1 , wherein applying GVS to the subject alters body mass composition.

3. The method of claim 2 , wherein altering body mass composition comprises decreasing total body fat, increasing relative percentage lean muscle mass, and increasing bone mineral density in the human subject.

4. The method of claim 1 , further comprising treating the at least one disease by applying GVS to the subject using an AC square wave at approximately 0.5 Hz with an approximately 50 percent duty cycle.

5. A method for treating at least one disease in a human subject, the method comprising:

connecting the subject with a device which produces an electrical current by disposing electrodes at the subject's scalp at a location corresponding to each of the subject's left and right vestibular systems; and

treating the at least one disease by applying galvanic vestibular stimulation (GVS) from the device to the subject via the electrodes using an AC square wave at approximately 0.5 Hz with an approximately 50 percent duty cycle, wherein the at least one disease is one or more of diabetes, type 2 diabetes mellitus, hypertension obesity, osteoporosis or an obesity-related disease.

6. The method of claim 5 , wherein applying GVS to the subject alters body mass composition.

7. The method of claim 6 , wherein altering body mass composition comprises decreasing total body fat, increasing relative percentage lean muscle mass, and increasing bone mineral density in the human subject.

8. The method of claim 5 , further comprising treating the at least one disease by applying GVS for a predetermined period of time at regular intervals.

9. The method of claim 8 , wherein the predetermined period of time is approximately one hour.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2018
From: RAMACHANDRAN, VILAYANUR S.; MCGEOCH, PAUL DUNCAN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 046293/0109 →
Continuity (3)
Continuation In Part 14770333
Provisional Application 61771766 · Mar 1, 2013
Related Publication 20170304616A1 · Oct 26, 2017
Cited By (1)
US 12,576,271